rs9264942

mixedMag 5.5

This is a intergenic variant variant in the HLA-C gene.

Key Literature Trait Associations

HIV-1 Viral Load Control

The C allele at rs9264942, located 35 kb upstream of HLA-C, is associated with lower HIV-1 viral load set point. In a GWAS of 2,362 HIV-1-infected individuals, this variant showed the strongest association with viral load control outside of HLA-B (p = 9.36e-26). The protective effect is mediated through higher HLA-C surface expression, enhancing cytotoxic T-lymphocyte responses against HIV-infected cells.

Fellay J et al. Common genetic variation and the control of HIV-1 in humans. Plos Genetics 5(12):e1000791 (2009)
Allele T
OR
β -0.300
p 6.0e-32
N 2,554
Large GWAS
European
Fellay J et al. A whole-genome association study of major determinants for host control of HIV-1. Science (new York, N.y.) 317(5840):944-947 (2007)
Allele T
OR
β -0.500
p 9.4e-26
Large GWAS
Thørner LW et al. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases (2016)
Allele T
OR
p 1.0e-4
N 1,897
Preliminary work
European
Allele T
OR
p
N 335
Candidate gene study
European
Allele T
OR
p
N 183
Candidate gene study
European

Psoriasis

The C allele at rs9264942, which tags high HLA-C expression, is also associated with increased susceptibility to psoriasis vulgaris. Majorczyk et al. (2014) found an OR of 5.04 for the C allele in a Polish cohort, though this effect is substantially weaker than that of HLA-Cw*06 (OR=15.61) and is largely dependent on HLA-Cw*06 co-carriage due to strong linkage disequilibrium. The dual role of this SNP in HIV protection and psoriasis risk is thought to reflect the pleiotropic consequences of elevated HLA-C expression on immune regulation in different tissue contexts.

Allele C
OR 5.04
p
N 546
Preliminary work
European
Allele C
OR
p
N 2,028
Preliminary work
multi-ancestry

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

HIV-1 infection

Pereyra F et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (new York, N.y.) 330(6010):1551-7 (2010)
Allele C
OR 2.90
p 3.0e-35
N 3,622
Large GWAS
multi-ancestry
Fellay J et al. Common genetic variation and the control of HIV-1 in humans. Plos Genetics 5(12):e1000791 (2009)
Allele C
OR 5.30
p 6.0e-32
N 2,362
Large GWAS
European

Crohn's disease

Allele C
OR 1.15
p 5.0e-28
N 34,366
Large GWAS
European

MHC class I polypeptide-related sequence A measurement

Allele C
OR 0.27
p 1.0e-20
N 2,935
Large GWAS
Greater Middle Eastern (Middle Eastern, North African or Persian)

ClinVar annotation

Risk Factor
1 submitter1 publication

HIV-1 VIREMIA, SUSCEPTIBILITY TO

View on ClinVar →

Research that mentions this SNP (1)

Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells
FunctionalN=66Hojjatollah Nozad Charoudeh et al.(2012)· Immunogenetics

This functional study of 66 healthy donors investigated whether HLA-C surface expression variants (rs9264942 and rs67384697) influence NK cell licensing through altered HLA-C quantity. While the number of HLA-C ligands dose-dependently increased NK cell degranulation and cytokine production, neither polymorphism nor absolute HLA-C surface quantity significantly affected NK cell function. Notably, HLA-Cw7, which has low surface expression, strongly licensed KIR2DL3+ NK cells more effectively than other C1 ligands.

Traits studied:HIV progressionNK cell functionNK cell licensing

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…